2ZOQ
Structural dissection of human mitogen-activated kinase ERK1
Summary for 2ZOQ
| Entry DOI | 10.2210/pdb2zoq/pdb |
| Descriptor | Mitogen-activated protein kinase 3, SULFATE ION, SODIUM ION, ... (5 entities in total) |
| Functional Keywords | serine/threonine kinase, erk1, acetylation, atp-binding, cell cycle, host-virus interaction, nucleotide-binding, phosphoprotein, polymorphism, serine/threonine-protein kinase, transferase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 2 |
| Total formula weight | 88077.91 |
| Authors | Kinoshita, T.,Tada, T.,Nakae, S.,Yoshida, I. (deposition date: 2008-06-01, release date: 2009-04-07, Last modification date: 2024-10-30) |
| Primary citation | Kinoshita, T.,Yoshida, I.,Nakae, S.,Okita, K.,Gouda, M.,Matsubara, M.,Yokota, K.,Ishiguro, H.,Tada, T. Crystal structure of human mono-phosphorylated ERK1 at Tyr204 Biochem.Biophys.Res.Commun., 377:1123-1127, 2008 Cited by PubMed Abstract: Extracellular signal-regulated kinase (ERK) is a member of the MAP kinase family, and can regulate several cellular responses. The isoforms ERK1 and ERK2 have markedly similar amino acid sequences, but exhibit distinctive physiological functions. As well as ERK2, ERK1 was auto- and mono-phosphorylated at Tyr204 in the activation loop during Escherichia coli production, resulting in basal level activity, approximately 500-fold less compared with fully-active ERK1 dual-phosphorylated at Thr202 and Tyr204. Crystal structure demonstrated that the mono-phosphorylated ERK1 kinase possessed a novel conformation distinguishable from the un-phosphorylated (inactive) and the dual-phosphorylated (full-active) forms. The characteristic structural features in both the C-helix and the activation loop likely contribute to the basal activity of the mono-phosphorylated ERK1. The structural dissection of ERK1 compared to ERK2 suggests that the structural differences in the D-motif binding site and in the backside binding site are putative targets for development of selective ERK1/ERK2 inhibitors. PubMed: 18983981DOI: 10.1016/j.bbrc.2008.10.127 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.39 Å) |
Structure validation
Download full validation report






